Cases & Deals

  • Home
  • Practices
  • XIO acquires Lumenis for approximately $510 million, $14 per share, in cash

Share

XIO acquires Lumenis for approximately $510 million, $14 per share, in cash

October 2015

Client(s) XIO Group

Jones Day advised XIO Group in its acquisition of Lumenis Ltd., the world's largest energy-based medical company for surgical, ophthalmology, and aesthetic applications, for $14 per share in cash, for an aggregate purchase price of approximately $510 million. Jones Day also assisted with the financing which consisted of a term loan, revolving loan, and a bridge loan provided by Mizrahi Tehafot Bank Ltd. ZELPEL acted as lead counsel with respect to the Israel law facility agreement.

In addition to M&A representation, Jones Day provided intellectual property and health care advice regarding this transaction.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.